Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimizing an Intervention to Increase Oral Medication Adherence for Metastatic Breast Cancer Patients

NCT06726889 is registered in ClinicalTrials.gov with European Institute of Oncology as lead sponsor.

NCT NCT06726889
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06726889 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimizing an Intervention to Increase Oral Medication Adherence for Metastatic Breast Cancer Patients
Lead sponsor
European Institute of Oncology
Phase
Observational
Overall status
Recruiting
Start date
January 25, 2024
Completion date
April 30, 2025
Enrollment
104 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer